Medtox Scientific (NASDAQ:MTOX) reported Q1 EPS of $0.17, topping estimates of $0.13.The company reported Q1 revenues of $28.6 million, vs. estimates of $27.5 million.The company reported gross margin of 41.5%, vs. estimates of 39.8% and the company says it has $7.0 million in cash as of quarter’s end.